Dr. Bruce Katz, MD, shares some emerging treatments in dermatology including:

1. The global facial injectables market size is expected to reach USD 9.07 billion by 2028 (the market size stood at USD 4.46 billion in 2020): What does this mean for aesthetic medicine providers, are there more ways to capitalize on this growth other than simply offering injectables?

2. Which new or emerging laser technology or treatment should providers have their eyes on, or consider offering in their practice if they don't already?

3. For someone interested in facial rejuvenation but hesitant to commit to surgery, which noninvasive or minimally invasive procedure delivers the best results with little downtime?

4. You practice both clinical and aesthetic dermatology – which field has the most growth potential for new practitioners? If a dermatology student or resident were deciding between dermatologic subspecialties, what would your advice to them be?

5. Your partnership with LiVDerm as faculty at many of our prestigious events draws quite a following. What do you think LiVDerm offers our attendees that other conferences do not? What are providers who've never been to a LiVDerm event missing?

6. February is Black History Month – LiVDerm has dedicated resources and programming to address dermatologic conditions that disproportionately affect or burden people with skin of color (SOC) such as African Americans. What is your experience in this area, and how can the dermatology community lessen these disparities?